https://www.selleckchem.com/pr....oducts/liraglutide.h
Loss in total and appendicular lean masses were found to be significantly associated with follow-up time. Low baseline percentage body fat (r = 0.72, p = 0.04), loss of percentage body fat (r = 0.81, p = 0.01), and total fat mass index (r = 0.73, p = 0.04) during follow up correlated significantly with monthly decline of ALSFRS-R scores in ALS cohort who had 2 or more follow-ups (N = 8). Measurement of body composition with DEXA might serve as a biomarker for rapid disease progression in ALS. Measurement of body composition with DEX
Gefällt mir
Kommentar
Teilen
